Prestige Consumer Healthcare Inc
PBH: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| t% | LOCK|<TC@? | LOCK|BhFt@$ |
Prestige Earnings: Continued Clear Eyes Variability Reduces Full-Year Outlook
Prestige Consumer Healthcare delivered second-quarter revenue growth of 23% this quarter (negative 2% organic), and adjusted EPS of 6%, both ahead of FactSet consensus. Management lowered full-year revenue and EPS guidance to midpoint figures of $1.29 billion and $4.52, respectively.
